Skip to main content

MetLife Value Stock - Dividend - Research Selection

Metlife

ISIN: US59156R1086 , WKN: 934623

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, tort settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers automobile, homeowners\', and personal excess liability, as well as small business owners\' property, liability, and business interruption insurance products. Further, it provides fixed annuities and pension products; medical and credit insurance products; variable, universal, term, endowment, and whole life insurance products; variable, and fixed and indexed-linked annuities; and protection against costs of long-term health care services. MetLife, Inc. has a strategic alliance with Ernst & Young LLP. The company serves individuals, corporations and their employees, and other institutions through independent agents, property and casualty specialists, sales forces, sales teams and relationship managers, and other organizations, as well as through career agency, bancassurance, direct marketing, brokerage, and other third-party distribution and e-commerce channels. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Morgan Stanley Maintains Overweight on MetLife, Raises Price Target to $111

2026-08-24
Morgan Stanley analyst Nigel Dally maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $103 to $111.

Life Insurance Stocks Q2 Recap: Benchmarking MetLife (NYSE:MET)

2026-08-20
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how MetLife (NYSE:MET) and the rest of the life insurance stocks fared in Q2.

MetLife (MET) Stock May Be 43% Undervalued On New $3B Buyback

2026-08-19
MetLife has delivered a strong 82.3% total return over the past five years, yet today the stock screens as expensive on traditional multiples while an Excess Returns intrinsic value estimate points to meaningful upside, so investors are getting mixed signals on what the current US$96.73 share price really implies. Over five years, MetLife has returned 82.3%, which puts recent valuation concerns in the context of a stock that has already created substantial shareholder value over a longer...

The Dividend Winners and Losers From 5% Treasury Yields

2026-08-19
When the 30-year Treasury topped 5%, two dividend stocks moved in completely opposite directions on the same day, and the reason has nothing to do with their yields.

Wells Fargo Maintains Overweight on MetLife, Raises Price Target to $109

2026-08-19
Wells Fargo analyst Wesley Carmichael maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $101 to $109.

4Pines Fund Services Appoints Brian Sciortino as Chief Operating Officer

2026-08-18
4Pines Fund Services today announced the appointment of Brian Sciortino as Chief Operating Officer, strengthening the firm's leadership team as it continues to expand its fund administration platform, client service capabilities, and operational infrastructure.

These 5 Dividend Stocks Show Why Income Investing Still Matters

2026-08-17
BlackRock, DLocal, Chevron, Williams Companies, and MetLife pay solid dividends and carry favorable analyst ratings, offering income investors growth exposure and price target upside.

MetLife 2025 Sustainability Report: Delivering Research and Insights

2026-08-17
NORTHAMPTON, MA / ACCESS Newswire / August 17, 2026 /MetLife MetLife publishes several annual studies and short-form articles, as well as hosting industry events and speaker series, to share insights that help us and our stakeholders better understand ...

MetLife’s Q2 Earnings Call: Our Top 5 Analyst Questions

2026-08-14
MetLife’s second quarter results were marked by broad-based earnings growth, with market participants rewarding the company’s performance as shares rose notably after the announcement. Management attributed the positive momentum to strong underwriting across all segments, increased international sales, and disciplined expense controls. CEO Michel Khalaf pointed to the impact of MetLife’s “New Frontier strategy,” which leverages recurring revenue streams and a diverse global portfolio, emphasizin

MetLife (MET) Q2 2026 Earnings Call Transcript

2026-08-13
Adjusted earnings surged 15% on strong underwriting and broad-based volume growth.